Incorporating an age threshold of 52 years, the study proposed an algorithm where patients under 52 with hs-cTnT < 0.069 ng/mL could forgo further CAD evaluation, while those older or with hs-cTnT > 0.069 ng/mL would be referred for coronary angiography. Here, TNNT2 is linked to coronary artery disorder.